Zhuo Qi, Yuan Zhengyong, Chen Hengxi, Wu Taixiang
West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.
Cochrane Database Syst Rev. 2010 May 12;2010(5):CD004468. doi: 10.1002/14651858.CD004468.pub2.
Stable angina pectoris is a common condition, worldwide. Traditional Chinese herbal products (TCHP) are developed for treating stable angina pectoris in China.
To assess the effectiveness and safety of TCHP in patients with stable angina.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 4, 2006), MEDLINE (1995 to June 2008), EMBASE (1995 to June 2008), the Chinese Biomedical Database (CBM) (1995 to June 2008), Chinese Science and Technique Journals Database (VIP) (1994 to June 2008) and Chinese National Knowledge Infrastructure (CNKI) (1995 to June 2008). We handsearched the relevant Chinese journals. We also contacted researchers in the field and authors of studies evaluated in this review for more information. No language restrictions were applied.
Randomised controlled trials comparing TCHP with placebo, various other TCHP preparations, or with other regimes commonly used currently in the treatment of stable angina.
Quality of studies was assessed independently by two authors. Data were extracted by one author and checked by the other one.
Three studies each with the number of participants ranging from 60 to 80, and a total of 216 participants, were included in this review. The interventions used in the included studies were different from one another. One study compared TCHP with nitrates and was of good methodological quality whereas the remaining two trials compared one preparation with another preparation and one was of poor methodological quality. As such, we were unable to perform a summary meta-analysis. Only one trial with small patient numbers showed positive results favouring TCHP treatment compared with nitrates, in improved angina symptoms. Two of the trials stated that adverse reactions occurred but detailed data could not be obtained.
AUTHORS' CONCLUSIONS: There is currently insufficient evidence for effectively treating stable angina pectoris with any of the examined TCHP in this review, due to the small number of included studies and participants. Therefore, TCHP should be used with caution. High quality randomised trials with similar interventions are required to strengthen the evidence for the effectiveness and safety of Chinese medicinal herbs in angina pectoris.
稳定性心绞痛在全球范围内是一种常见病症。中国研发了传统中草药产品(TCHP)用于治疗稳定性心绞痛。
评估TCHP治疗稳定性心绞痛患者的有效性和安全性。
我们检索了Cochrane对照试验中心注册库(CENTRAL)(2006年第4期《Cochrane图书馆》)、MEDLINE(1995年至2008年6月)、EMBASE(1995年至2008年6月)、中国生物医学文献数据库(CBM)(1995年至2008年6月)、中文科技期刊数据库(VIP)(1994年至2008年6月)和中国知网(CNKI)(1995年至2008年6月)。我们手工检索了相关中文期刊。我们还联系了该领域的研究人员以及本综述中评估的研究的作者以获取更多信息。未设语言限制。
比较TCHP与安慰剂、其他各种TCHP制剂或与目前治疗稳定性心绞痛常用的其他疗法的随机对照试验。
研究质量由两位作者独立评估。数据由一位作者提取并由另一位作者核对。
本综述纳入了3项研究,每项研究的参与者人数在60至80人之间,总共216名参与者。纳入研究中使用的干预措施各不相同。一项研究将TCHP与硝酸盐进行了比较,方法学质量良好,而其余两项试验将一种制剂与另一种制剂进行了比较,其中一项方法学质量较差。因此,我们无法进行汇总的Meta分析。只有一项样本量较小的试验显示,与硝酸盐相比,TCHP治疗在改善心绞痛症状方面有积极结果。两项试验表明发生了不良反应,但无法获得详细数据。
由于纳入的研究和参与者数量较少,目前本综述中没有足够的证据表明所研究的任何一种TCHP能有效治疗稳定性心绞痛。因此,应谨慎使用TCHP。需要高质量的类似干预措施的随机试验来加强中药治疗心绞痛有效性和安全性的证据。